Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AVEO PHARMACEUTICALS, INC. | d846897dex322.htm |
| EX-32.1 - EX-32.1 - AVEO PHARMACEUTICALS, INC. | d846897dex321.htm |
| EX-21.1 - EX-21.1 - AVEO PHARMACEUTICALS, INC. | d846897dex211.htm |
| EX-31.1 - EX-31.1 - AVEO PHARMACEUTICALS, INC. | d846897dex311.htm |
| EX-31.2 - EX-31.2 - AVEO PHARMACEUTICALS, INC. | d846897dex312.htm |
| EX-10.27 - EX-10.27 - AVEO PHARMACEUTICALS, INC. | d846897dex1027.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - 10-K - AVEO PHARMACEUTICALS, INC. | d846897d10k.htm |
| EX-10.30 - EX-10.30 - AVEO PHARMACEUTICALS, INC. | d846897dex1030.htm |
| EX-10.28 - EX-10.28 - AVEO PHARMACEUTICALS, INC. | d846897dex1028.htm |
| EX-10.35 - EX-10.35 - AVEO PHARMACEUTICALS, INC. | d846897dex1035.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165530 and 333-175390 and Form S-3 Nos. 333-178756 and 333-174254) of AVEO Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 6, 2015, with respect to the consolidated financial statements of AVEO Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of AVEO Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 6, 2015